CTLA4 and glioblastoma: Moreover, NT5E-/- mice with GBM exhibit prolonged survival following treatment with anti-CTLA-4 and anti-PD-1 suggesting that NT5E may be a causative factor in failures of the immunotherapy of GBM [206].